1. 330 Investigating the clinical safety, efficacy, and immune modulation of combined XL888 and pembrolizumab in metastatic gastrointestinal malignancies. (10th December 2020) Authors: Herting, Cameron; Zhang, Yuchen; Doxie, Deon; Farren, Matthew; Ware, Michael; Alese, Olatunji; Wu, Christina; Shaib, Walid; Akce, Mehmet; Zaidi, Mohammad; Ruggieri, Amanda; Dhodapkar, Madhav; Dhodapkar, Kavita; Sarmiento, Juan; Ahmed, Rafi; Maithel, Shishir; El-rayes, Bassel; Lesinski, Gregory Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 330 Investigating the clinical safety, efficacy, and immune modulation of combined XL888 and pembrolizumab in metastatic gastrointestinal malignancies. (9th November 2020) Authors: Herting, Cameron; Zhang, Yuchen; Doxie, Deon; Farren, Matthew; Ware, Michael; Alese, Olatunji; Wu, Christina; Shaib, Walid; Akce, Mehmet; Zaidi, Mohammad; Ruggieri, Amanda; Dhodapkar, Madhav; Dhodapkar, Kavita; Sarmiento, Juan; Ahmed, Rafi; Maithel, Shishir; El-rayes, Bassel; Lesinski, Gregory Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A356 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗